VistaGen Therapeutics Inc. (VTGN)
NASDAQ · Healthcare
VistaGen Therapeutics Inc. Cash on Hand 2011–2025
VistaGen Therapeutics Inc. annual cash on hand history from 2011 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- VistaGen Therapeutics Inc. cash on hand as of March 31, 2025: 67.1M, a 43.67% decrease year-over-year.
- VistaGen Therapeutics Inc. cash on hand for 2025 were 67.1M, a 43.67% decrease from 2024.
- VistaGen Therapeutics Inc. cash on hand for 2024 were 119.2M, a 616.23% increase from 2023.
- VistaGen Therapeutics Inc. cash on hand for 2023 were 16.6M, a 75.58% decrease from 2022.
- VistaGen Therapeutics Inc. cash on hand for 2022 were 68.1M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| VistaGen Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $67 |
| 2024 | $119 |
| 2023 | $17 |
| 2022 | $68 |
| 2021 | $103 |
| 2020 | $1 |
| 2018 | $10 |
| 2017 | $3 |
| 2016 | $0 |
| 2013 | $1 |
| 2012 | $0 |
| 2011 | $0 |
VistaGen Therapeutics Inc. Cash on Hand — FAQ
VistaGen Therapeutics Inc. (VTGN) cash on hand over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VTGN's cash on hand history?
The chart and table above show VistaGen Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.